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Virus  infection  in  man  may  lead  to  acute,  subacute,  or  chronic  illness. 
Although  the source of entry,  type of virus, preferred tissue of infection,  and 
mechanism of replication of the virus are important,  the manner in which the 
host interacts with the virus-infected cell determines,  in large part,  the infec- 
tion's outcome and the type of disease which results. Host defenses against virus 
and virus-infected cells operate at humoral [antiviral antibody and complement 
(C)]  (1-3),  cellular  (sensitized T  cells, macrophages)  (4,  5),  and combined hu- 
moral-cellular  (K cells, macrophages)  (6) levels. Although these various path- 
ways have been described in some detail, little is known of the cellular receptors 
involved,  the  quantitative  aspects of the  reaction,  or the  biochemical  events 
which lead to lysis of virus-infected cells. While these mechanisms and probably 
others  function  simultaneously  in  vivo,  we believe  that  the  host's  defenses 
against virus infection will be better understood only after each type of reaction 
has been characterized in detail. 
We have focused initially on humoral defense mechanisms and the interaction 
of antibody and/or C with various viruses (7, 8) and with virus-infected cells (9). 
The  latter  studies  indicated  that  1  x  10  ~ HeLa cells  acutely or persistently 
infected with measles virus consistently can bind from 1 to 7 ~g of immune IgG 
at their surface (9, 10). Such cells are lysed by antibody and C, but only when an 
average of more than 1 x  10" molecules of antiviral  antibody became bound to 
each infected cell (9). Furthermore,  we found that antibody-initiated C-depend- 
ent lysis of several different cell types expressing surface measles virus antigens 
was mediated exclusively by the alternative C pathway (9). 
Now  we  report  antibody-mediated  lysis  of cells  expressing  mumps  virus, 
herpes simplex Type I virus, influenza A ° virus, or measles virus antigens. Lysis 
of cells infected with these RNA and DNA budding viruses was dependent on 
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the  presence of specific  antibody  and  proceeded through  the  alternative  C 
pathway. Lysis was initiated by human IgG antibody, or its F(ab')2,  but not 
Fab' or Fc fragments. 
Materials and Methods 
Viruses and Cell Lines.  Mumps virus, herpes simplex type 1 virus, and measles virus (Edmon- 
ston strain) were obtained from the American Type Culture Collection, Rockwell, Md. Influenza 
A°/WSN was a gift of Martin Haspel, Scripps Clinic and Research Foundation, La Jolla, Calif. as 
was Clone 7-5e-4 of the Wang Kilbourne variant of the Chang conjunctiva cell line. HeLa and Vero 
cells were obtained from Flow Laboratories Inc., Rockville, Md. After passage at low multiplicities 
of infection (MOI) (0.1-0.4) in Vero cells for mumps virus, in HeLa cells for herpes simplex type 1 
virus and measles virus, and in Chang conjunctiva cell lines for influenza A ° virus, pools of the 
respective infectious viruses were collected,  separated from cellular debris by centrifugation (5 
min, 1,000 g), divided into aliquots, and stored at -70°C until use. The various virus pools were 
titrated as described (9). 
Cultivating,  Infecting,  and Handling  of Cells.  Vero and HeLa cell lines were cultivated in 
Eagle's minimal essential media (MEM) ~ with 10% heat-inactivated fetal calf serum, glutamine, 
and  antibiotics;  Chang  conjunctiva  cells were  grown  in  MEM  containing 0.2%  bovine  serum 
albumin, glutamine,  and antibiotics at the time of infection. During the late log phase of their 
growth in 75 CM  3 Falcon flasks (Falcon Plastics, Oxnard, Calif.), the cells were infected with the 
different virus preparations at an average MOI of 3. After 2 h of absorption, during which the cells 
and viruses were gently mixed on a Bellco rocker platform (Bellco Glass Inc., Vineland, N. J.) at 
37°C in 5% CO2,  the cultures were supplemented with 20 ml of appropriate growth media. Cells 
infected with mumps virus or measles virus were harvested 3-4 days after infection, whereas cells 
infected with herpes simplex virus or influenza virus were used 1-2 days after infection. Such cells 
were  obtained  after vigorously shaking each  flask,  then removing and discarding the  loosely 
adherent cells. Afterward we treated the adherent cells with trypsin-EDTA as previously reported 
(9). Preliminary studies indicated that 99% of cells harvested in this method showed viral antigens 
on their surfaces and greater than 95% viability as judged by trypan blue dye exclusion tests. 
Source  of Antiviral Antibody and C.  Human sera were obtained from 13 healthy laboratory 
workers,  two children without known exposure to mumps virus, one 30-yr-old male before and 
after mumps vaccination, one 12-me-old infant before vaccination against measles virus, and three 
women with recurrent herpes simplex type 1 virus infections. Each bleeding was collected in a 
glass tube and left standing 2 h at room temperature. The sera were centrifuged and used directly 
or after storage at -70°C as sources of both antiviral antibody and C. 
IgG Fragments.  The IgG fraction from serum of a patient with subacute sclerosing panenceph- 
alitis  (SSPE)  was  kindly provided by Peter Lachmann,  Royal  Postgraduate Hospital,  London. 
Approximately 12% of this IgG preparation contained specific antibodies for measles virus antigen 
(10). Less than 1% of IgG prepared from the sera of two subjects having antibodies against mumps 
virus and measles virus contained specific antibodies to measles or mumps virus.  After ammo- 
nium  sulfate  precipitation  and  DEAE  cellulose  chromatography,  both IgG preparations  were 
concentrated to 30 mg protein/ml by negative pressure, dialyzed against Veronal-buffered saline 
containing Mg+ +  and Ca+ +  (VBS+ +), centrifuged 10 min at 10,000 g, and shown to be pure by 
Ouchterlony analysis. F(ab')~ and Fab' were made as previously reported (11). F(ab')~ was reduced 
with  0.02  M  dithiothreitol for  2  h  at  20°C  and  alkylated  by  addition  of 0.05  M  recrystallized 
iodoacetamide to obtain Fab' that was subsequently chromatographed on Sephadex G100. F(ab')~ 
and Fab' preparations were concentrated to 20 mg/ml, dialyzed against VBS+ +, and, when tested 
by Ouchterlony analysis for specific antiserum directed against human Fc or human Fab' frag- 
ments (kindly provided by Dr. H. Spiegelberg, Scripps Clinic and Research Foundation, La Jolla, 
Calif.),  showed a  precipitin line only with antibody directed toward human Fab',  but not with 
antibody against human Fc. 
' Abbreviations  used  in this paper:  MEM,  Eagle's minimal essential media;  SSPE,  subacute 
sclerosing panencephalitis; VBS+ +, Verenal-buffered saline containing Mg+ +  and Ca+ +. PERRIN~ JOSEPH~ COOPER~ AND OLDSTONE  1029 
Components and Antisera.  Factor B and C2 were purified from human sera as published (12, 
13). Factor B was immunochemically pure as determined by Ouchterlony analysis at a concentra- 
tion of 1.5 mg/ml. C2 was functionally pure and immunochemically free of Factor B. 
Human sera containing antibodies to measles virus were depleted of either C4 or factor B by the 
following procedures. 4 ml of sera containing 0.015  M EDTA and 0.4  M NaC1  per ml were run 
through columns of Sepharose 4B to which IgG fraction of antisera to C4 or Factor B had been 
coupled  (14); effluents were  collected and  concentrated by  negative  pressure  to  the  original 
starting volume and finally dialyzed against VBS+ +. All manipulations were carried out at 4°C. 
Some sera were depleted of factor B by heating at 50°C for 25 min. Depleted sera were used directly 
or stored in small aliquots at -70°C until use. Sera depleted of factor B retained over 75% of the 
original hemolytic C activity against sheep red blood cells sensitized with antibody (greater than 
50 CH:,. U) in each preparation, but sera depleted of C4 lost more than 99.9% of their hemolytic 
activity.  By  hemolytic plaque  assay  (15) sera depleted of factor B  had  no reactivity, whereas 
addition of 250 ~g purified factor B per ml of depleted sera gave ring size that was equivalent to 
untreated normal sera. C3 consumption after the addition of inulin was also measured in factor B- 
depleted and  repleted sera.  These  tests showed loss of ability  to  sustain  C3  consumption on 
addition of inulin and full reconstitution of this ability by isolated factor B. C4-deficient serum was 
fully able to mediate inulin-induced C3 consumption (12). Factor B- and C4-depleted sera were free 
of the respective protein when tested by Ouchterlony analysis with the specific antisera. 
Antisera against human properdin were raised in rabbits and antisera against factor B and C3 
in goats. All these antisera were free of contaminants, as judged by Ouchterlony analysis, except 
the rabbit antiproperdin which contained trace amounts of antibodies to human IgG. The contami- 
nating  anti-IgG  was  completely absorbed  out  by  using  human  IgG  insolubilized  with  ethyl 
chloroformate (16). IgG was isolated from antifactor B and anti-C4 antisera, and 50 mg of each was 
coupled to 15 ml of Sepharose 4B (14) to make various affinity columns. Rabbit antibody to HeLa 
cells was made and characterized as reported (9). 
Goat antihuman C4 and antihuman factor B were mixed at equivalence with normal human 
serum in the presence of 0.01 M EDTA. The precipitate that formed overnight at 4°C was washed 
with phosphate-buffered saline, dissolved in glycine HCI,  and digested with pepsin according to 
Lachmann (17). After centrifugation at 3,000 g  for 5 min, the supernate was collected, dialyzed 
against 0.05  M Tris buffer pH 8.2,  reduced with DDT,  and alkylated with iodoacetamide.  After 
chromatography  on  Sephadex  G100  the  Fab'  fragments  were  dialyzed  against  VBS+ +  and 
adjusted to a protein concentration of 6 mg/ml. The preparations were free of any Fc contamina- 
tion by Ouchterlony analysis. 
To examine the ability of Fab antisera to C components to block the C system, 100 ~l of Fab' 
antibody to C4 or factor B were mixed with 100 ~l of fresh human serum containing antibody to 
measles virus, mumps virus, influenza virus, or herpes viruses for 10 min at room temperature. A 
100-~l  aliquot was removed, and two-fold serial dilutions were made with the fresh serum until a 
final dilution of Fab reagents were 1:16. Various dilutions of these mixtures were tested for their 
ability to lyse virus-infected target cells by using the microcytotoxicity assay (see below). 
Immunofluorescence.  The IgG fractions of sera containing monospecific antibodies to C4,  C3, 
factor B, and properdin were conjugated to fluorescein isothiocyanate as previously reported (18). 2 
vol of fluoresceinated antisera were absorbed with 1 vol of uninfected target cells at 4°C for 3 h to 
remove natural antibodies against cell surface determinants. The fluoresceinated antisera did not 
stain the surfaces of  uninfected or virus-infected  cells grown in growth medium after absorption. 
We also used immunofluorescence (direct) to test for measles virus antigens on the surfaces of 
infected ceils and  (indirect) for the  presence of mumps virus,  influenza A  ° virus,  and  herpes 
simplex type 1 viruses. 
Cytoxicity.  To measure cell lysis we used the eosin micromethod described by Joseph et al. (9} 
with the following modifications: (a)  for reconstituting C components after depletion, 1-2  ~l of 
purified C components were added; (b) 8 ~l of immune or nonimmune sera depleted of various C 
components were used, and (c) control sera were supplemented with 1-2 ~l of VBS+ +. The results 
were expressed either as a cytotoxicity index corrected by removing spontaneously dead cells or as 
the percentage of dead cells. Nonspecific background lysis never exceeded 10% with a mean of 5% 
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Results 
Specificity  of Antibody-Initiated  C-Dependent  Lysis  of Cells Infected  with 
Mumps, Herpes Simplex,  Influenza  A,  or Measles Viruses.  Vero  cells  were 
susceptible  to infection with  mumps  virus  as  evidenced by the  appearance  of 
viral antigens in the cytoplasm and on the cells' surfaces 24-48 h  after addition 
of virus  to  the  cells.  Results  were  similar  when  herpes  simplex  virus  and 
measles  virus  were  added  to  HeLa  cells,  and  influenza  virus  was  placed  on 
Chang conjunctiva cells.  These different virus-infected cells were only used at 
the  time  when  more  than  95%  of them  were  positive  by  direct  or  indirect 
fluorescence.  When  fresh  sera  from over  15  persons  containing  antibodies  to 
these various viruses were added to cells infected with the corresponding virus 
48 h or more after initiating infection, cell lysis occurred. Prior heating of these 
sera at 56°C  for 30 min eliminated the lytic effect. However, heated sera could 
initiate  lysis when replenished  with a  source of C  devoid of specific antiviral 
antibodies. 
The specificity of the lytic process was shown in several ways (Tables I and II): 
(a)  Virus-infected  cells  were  lysed  only  in  the  presence  of IgG  (presumably 
antiviral antibody) that could be detected by immunofluorescence. Neither IgG 
binding  nor specific cell  lysis occurred with  uninfected cells.  (b)  Sera having 
antibody to only one virus and capable of mediating lysis of cells infected with 
that virus were unable to lyse cells infected with other viruses (Table I). (c) Sera 
that did not contain immune IgG to a  specific virus and that were incapable of 
lysing cells infected with that virus acquired lytic ability when we added IgG 
from sera that contained antibody to that virus. An example is shown for mumps 
virus-infected cells in Table II. In a few instances, primarily with cells infected 
with herpes simplex Type I  virus,  IgG bound to the infected cells despite the 
absence of lysis. This may have been caused by Fc receptors which appeared on 
cells after  infection with  this  virus  (19)  or to  an  inadequate  concentration of 
antiviral antibody. 
Further evidence for specificity was observed when we used serum from an 
individual  without  a  history  of mumps  virus  infection  and  no  evidence  of 
antibodies to mumps virus to lyse Vero cells expressing mumps viral antigens 
on  their surface  before and  after specific  vaccination.  As  seen  in  Fig.  1,  the 
prevaccination serum and serum obtained 3 days after vaccination were unable 
to lyse cells infected with mumps virus.  Lysis of mumps virus-infected cells by 
serum from this individual first occurred 6 days after vaccination and a  serum 
sample obtained 10 days after vaccination was able to kill over 95% of mumps 
virus-infected Vero cells. Similarly, using a  serum devoid of antibodies against 
mumps  virus  and  adding  various  amounts  of mumps  virus-immune  IgG  ob- 
tained from two different subjects, it was shown that the percent of cells lysed 
depended on the amount of immune IgG added (Fig. 2). At no time were the sera 
used able to injure  uninfected Vero cells.  The presence of IgG able to bind to 
infected cells correlated well with the lytic capacity of the serum.  In this as all 
other studies, IgG did not bind to uninfected Vero cells, and infected cells were 
not lysed after heating the serum for 30 min at 56°C. 
Pathway  of  C  Activation  in  Antibody-Initiated  Injury  of  Virus-Infected 
Cells.  The cytolytic activity of fresh serum  containing antibody for cells ex- PERRIN,  JOSEPH,  COOPER,  AND  OLDSTONE  1031 
TABLE  I 
Specificity  of Antibody-Initiated Complement-Dependent Lysis of Cells Expressing Viral 
Antigens on Their Surfaces* 
Cells expressing antigens of the following viruses: 
Mumps virus  Herpes simplex I virus  Influenza A  virus  Measles virus 
Fresh 
serum  Percent lysis  Percent lysis 
source  Bind-  with  Bind-  with 
ing of  ing of 
IgG  Fresh  A56  IgG  Fresh  A56 
serum  serum  serum  serum 
Percent lysis  Percent  lysis 
Bind-  with  Bind-  with 
ing  of  ing  of 
IgG  Fresh  A56  IgG  Fresh  A56 
serum  serum  serum  serum 
LP  0  7  7  +  95  5  +  95  10  ND  ND  ND 
BJ  +  86  6  +  99  5  +  87  10  +  10  10 
JM  +  76  5  +  95  5  ND  ND  ND  +  96  10 
JH  +  91  6  +  84  5  ND  ND  ND  +  9  8 
ZB  ND  ND  ND  +  87  5  +  79  10  +  83  9 
BB  0  5  5  0  5  5  0  7  7  +  8  7 
* 0, negative; +, positive; ND, not done. 
TABLE II 
IgG Dependence  of Complement-Mediated Lysis of Cells Expressing 
Mumps Viral Antigens on Their Surface* 
Immune reagents  Binding of IgG 
Percent lysis with 
Fresh se-  Serum 
rum  A56°C$ 
IP serum  0  7  7 
BB serum  0  5  5 
LP serum  0  7  7 
BJ serum  +  88  6 
BJ IgG  +  0  0 
BJ IgG + JP serum§  ND  82  6 
BJ IgG +  BB serum§  ND  84  7 
BJ IgG +  LP serum§  ND  83  7 
* o, negative; +, positive; ND, not done. 
$ These sera were heated at 56°C for 30 min. 
§ 2  tLl of BJ  IgG (30 mg/mD  were  added to 8  ill of JP,  BB,  and  LP sera, 
respectively. 
pressing  either  mumps  virus,  herpes  simplex  virus,  influenza  A °  virus,  or 
measles virus antigens  on their surfaces was sensitive to dilution.  Over 85% of 
the cytolytic activity disappeared at a  1:4 dilution for each of these viruses, even 
when the fresh sera were diluted in the same heated sera (56°C, 30 min) to make 
the  antibody  concentration  constant.  Moreover,  at  this  dilution,  significant 
binding  of IgG  to  infected  cells  occurred  in  several  sera,  indicating  that  the 
factor limiting lysis was the C  system and not the IgG. In contrast, the same C 
source diluted 1:50 retained over 50% of its original cytolytic titer for sheep red 
blood cells sensitized with antibody or uninfected HeLa cells coated with rabbit 
anti-HeLa  cell antibodies. 
Other  experiments  (Table  III)  showed  that  antibody-initiated  C-dependent 
lysis  of  virus-infected  cells  required  magnesium  but  not  calcium.  In  these 
studies, antibody containing fresh sera chelated with 11 mM EDTA and supple- 1032  ANTIBODY  AND  ALTERNATIVE  C  PATHWAY-MEDIATED  LYSIS 
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FIG.  1.  Ability of serum from an individual previously not exposed to mumps virus to lyse 
acutely infected vero cells after vaccination.  Serum was collected before, at,  and  after 
specific mumps vaccination and added to Vero cells expressing mumps virus antigens on its 
surface. Lysis was measured by microcytotoxicity  as described in Materials and Methods. 
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Fza.  2.  Ability of varying amounts of IgG antibody to mumps virus in the presence of a 
human C source devoid of antimumps virus antibodies in lysing Vero cells. Vero cells were 
acutely infected with mumps virus and were expressing viral antigens on their surface at 
the time of the test. Antibodies were obtained from a  convalescent serum (A  A)  and 
from a  serum after vaccination (©  ©). 
mented with I mM Mg+ +  were unable to mediate lysis of cells expressing virus 
antigens  on their  surfaces.  In contrast,  sera chelated with  11 mM EGTA and 
supplemented with 1 mM Mg+ +  were fully active (Table III). 
The  sensitivity  to  dilution  and  the  lack  of calcium  dependence  strongly 
suggested primary involvement of the alternative  C pathway in the lytic proc- 
ess.  In  accordance  with  this  interpretation,  the  cytolytic potential  of serum 
containing  antibodies  to  measles  virus  for  HeLa  cells  infected  with  measles 
virus  was  not reduced  after  depletion  of C4  by affinity chromatography,  al- 
though the ability of the C4-depleted sera to lyse sensitized sheep red blood cells 
was completely abolished by this procedure (over 95% of measles virus-infected 
HeLa cells were lysed by sera from two individuals either intact or depleted of 
C4). To better assess the role of the alternative C pathway in antibody-initiated 
lysis of virus-infected cells, sera were depleted of factor B either by heating at 
50°C for 25 min or by affinity chromatography (Table III). Both procedures led to 
complete loss of ability to lyse mumps virus, herpes simplex virus, influenza A ° 
virus,  and measles virus-infected cells. The lytic ability of the sera were fully 
reconstituted by physiological amounts of highly purified factor B  (Table III). 
Moreover, isolated C2, in excess, was unable to reconstitute the lytic activity in 
sera depleted of factor B. Similarly, the lytic activity for mumps virus-infected PERRIN,  JOSEPH,  COOPER,  AND  OLDSTONE  1033 
TABLE III 
Role of the Alternative C Pathway in Antibody-Initiated  Lysis of Virus-Infected Cells* 
C  source treatment 
Percent lysis after addition of human serum to cells expressing 
antigens of the following viruses$ 
Herpes sim-  Influenza vi-  Measles virus 
Mumps virus  plex I virus  rus 
None§  78  ±  10  87  ±  7  81  _+  7  90  ±  8 
Heated 50°C  20 rain  5  ±  10  10  ±  5  10  ±  5  5  ±  10 
Heated  50°C  20  min  +  84  ±  3  87_+  8  86  ±  10  88  ±  6 
factor B (250 t~g/ml) 
Fab antifactor B  5  ±  5  10  ±  5  10  _+  5  5  ±  5 
Fab anti-C4  74  ±  11  82  ±  5  78  ±  8  87  ±  9 
MgEGTA  75  ±  5  83  ±  6  79-+  7  85  +  3 
MgEDTA  5  ±  5  10_~  5  10±  5  5  ±  5 
* Spontaneous lysis of infected cells was 5  ±  10% for mumps and measles and 10  -+  5% for herpes 
simplex I  and influenza viruses. 
Values indicate  the mean  ±  SD for at least five different immune sera for cells infected with 
each virus. 
§ Untreated fresh immune serum. 
cells of serum lacking mumps virus antibody and reconstituted with immune 
IgG  (8  mg/ml)  was  lost  after heating  of the  serum  at  50°C for 25  min  and 
reconstituted  by  addition  of 250  ~g/ml  of factor  B.  Another  approach  was 
employed to assess the relative roles of the alternative and classical C pathways 
in lysis of virus-infected cells in these studies. This is based on our finding that 
Fab' antibody to factor B and Fab' antibody to C4 specifically block the alterna- 
tive and classical pathways, respectively. As shown in Fig. 3 the addition of Fab' 
antifactor B completely blocked cytolysis mediated by the alternative C path- 
way, while Fab' anti-C4 had no effect. Conversely, Fab' antibody to C4 blocked 
lysis of HeLa cells coated with rabbit antibody to HeLa cells, a  lytic reaction 
mediated by the classical pathway, whereas Fab' antibody to factor B did not. 
Lysis was blocked to a  dilution of the Fab' anti-C4 of 1:8. We tested 8 different 
immune  sera  to  mumps  virus,  5  immune  sera  to  herpes  simplex  virus,  11 
immune  sera  to  influenza  virus,  and  10  sera  to  measles  virus  with  these 
reagents.  In all  cases the addition of Fab'  antibody to factor B  to the  serum 
completely abrogated the cytolytic potential of these sera against cells infected 
with the respective virus (Table III). In contrast the addition of Fab' antibody to 
C4 had no significant effect on the ability of the sera to lyse cells infected with 
mumps virus, herpes simplex virus, influenza A ° virus, or measles viruses. 
Binding of Various C Components to Surfaces of Virus-Infected Cells.  We 
next  studied  the  binding  of properdin,  factor  B,  C3,  and  C4  to  the  plasma 
membranes of HeLa cells infected with measles after incubation of these cells 
with human immune sera (Fig. 4).  10" infected HeLa cells expressing measles 
virus antigens on their surfaces were incubated for 30 min with either growth 
medium, human serum containing antibodies to measles virus with the same 
serum depleted of C4, factor B, or properdin. Then these cells were washed and 
mixed with fluorescein-conjugated antiserum to properdin, factor B, C3,  or C4. 
Virus-infected  cells  incubated  with  growth  media  alone  failed  to  show  any 1034  ANTIBODY  AND  ALTERNATIVE  C  PATHWAY-MEDIATED  LYSIS 
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FIo.  3.  Inhibition of the ability of measles virus-specific antibodies and C to lyse HeLa 
cells acutely infected with measles virus upon the addition of goat Fab' antihuman Factor B 
(O  ©). In contrast lysis was not inhibited upon addition of either goat Fab' antihuman 
C4 (0  D) or VBS++  (A  A). 
staining on their plasma membranes. In contrast, greater than 95% of infected 
cells mixed with immune serum bound C3. Infected cells mixed with C4-depleted 
sera bound both properdin and factor B (Fig. 4). In all instances observed, factor 
B binding was significantly  less intense than the binding of  other C components. 
When factor B-depleted serum was used, we observed binding of  both properdin 
and C4 to the cells' surfaces. In other experiments both heated serum (56°C for 
30 min) and serum from a child devoid of antibodies against measles virus failed 
to induce binding of C components to the surfaces of infected cells. 
Portion  of  the  IgG  Molecule Which  Initiates  C  Lysis  of  Virus-Infected 
Cells.  IgG and F(ab')2 (15 mg/ml) antibody to mumps virus or measles virus in 
the presence of a  C source devoid of antiviral antibodies lysed cells expressing 
mumps or measles virus antigens on their surfaces, respectively (Table IV).  In 
contrast,  Fab'  (15  mg/ml) from either antivirus preparation was not able  to 
initiate lysis. Comparable studies with ~"SI-labeled F(ab')2 and ~25I-Fab' showed 
binding of approximately 5  ×  10  ~ and 8  ×  10" molecules of either fragment per 
cell under the prevailing experimental conditions, indicating that the inability 
of Fab' to initiate lysis was not due to the failure to bind. Also, unlabeled Fab' 
inhibited binding of ~2~I-IgG to infected cells. Similar results were obtained with 
IgG, F(ab'): (4 mg/ml), and Fab' (4 mg/ml) isolated from the serum of a patient 
with chronic measles virus infection (SSPE). 
Heating the nonantibody-containing C source at 50°C for 25 min prevented 
IgG-  or  F(ab')2-initiated lysis  of infected cells.  Lytic ability was  completely 
restored by the addition of  physiological amounts of highly purified factor B (250 
/zg/ml) to the heated C source (Table IV). 
Relationship  of Capping  of Virus Antigens  to Antibody-Mediated  Lysis  of 
Virus-Infected  Cells.  Immune lysis of cells expressing virus antigens on their 
surfaces proceeded independently of redistribution and capping of viral anti- 
gens. Thus,  when HeLa cells expressing measles virus antigens on their sur- 
faces were incubated with various concentrations of cytochalasin B and tested 
for their ability to be lysed by antibody and C or to redistribute surface viral 
antigens (Table V), we found that 5/zg/ml of cytochalasin B inhibited capping 
36%, while not abrogating immune lysis at all. Similarly, at 20/zg/ml capping PERRIN,  JOSEPH,  COOPER,  AND  OLDSTONE  1035 
FIG.  4.  Presence of human C3  (a) and human properdin (b) on the surface of HeLa cells 
acutely infected with measles virus. Living infected cells were incubated with fresh human 
serum containing antibodies against measles virus before staining with a  fluoresceinated 
goat monospecific antibody to human C3 or human properdin. 1036  ANTIBODY  AND  ALTERNATIVE  C  PATHWAY-MEDIATED  LYSIS 
was inhibited over 95%, whereas in contrast, lysis was not impeded. Comparable 
results occurred with concentrations  of sodium azide which inhibited  capping 
without abrogating immune cytolysis. Background lysis of virus-infected cells 
was not appreciably increased after the application of either inhibitor. 
Discussion 
Cells infected with mumps virus,  herpes simplex virus,  influenza  A ° virus, 
and measles virus were lysed upon the addition of fresh serum containing both 
antibody specific for their  respective viruses and  a  functional  C  source.  Only 
sera containing IgG able to bind to cells expressing the specific viral antigens 
caused injury. Study of cells infected with mumps, ~ herpes simplex, 2 or measles 
virus revealed that more than  1  x  10" molecules of IgG must bind to infected 
cells to  initiate  C-dependent  lysis.  Absolute specificity was observed in  that 
fresh sera lacking antibody to a  given virus were unable to lyse cells infected 
with that virus, although they acquired this ability after the addition of human 
IgG containing specific antiviral antibody (Fig. 2, Table II). Further evidence for 
specificity of this lytic process resulted from sequential studies of the ability of a 
serum from an individual with no evidence of immune responsiveness to mumps 
virus to lyse Vero cells expressing mumps viral antigens before and after specific 
vaccination.  Whereas no cytolytic activity was present in sera taken before or 3 
days after  specific vaccination,  cytolysis began  6  days after vaccination  and 
reached its peak by the 10th day after vaccination. The appearance of IgG that 
bound to infected cells paralleled the acquisition of cytolytic ability. 
The involvement of the C system in antibody-initiated lysis of cells infected 
with  measles,  mumps,  herpes  simplex  type I,  and  influenza  A ° viruses  was 
analyzed in detail.  Earlier studies with measles virus  (9) had shown that the 
cytolytic system was markedly sensitive to dilution  and required  magnesium 
but not calcium.  These findings implied alternative  pathway mediation of the 
lytic  event,  an  impression  substantiated  by the  full  cytolytic ability  of C2- 
deficient human serum and an absolute requirement for factor B for lysis. The 
alternative pathway route for lysis of measles virus-infected cells was confirmed 
in the present studies, since lysis of HeLa cells infected with measles by fresh 
human  serum  containing  antibody  was  sensitive  to  dilution,  independent  of 
calcium, and dependent on factor B. Human serum immunochemically depleted 
of C4 could still produce lysis, yet serum immunochemically depleted of factor B, 
but containing antibody, could not lyse infected cells unless reconstituted with 
physiological concentrations of factor B. In addition, human antibody-initiated 
lysis of mumps, herpes simplex Type I, and influenza A ° virus-infected cells also 
depended absolutely on the presence of factor B and also on magnesium, but not 
calcium.  Although  serum  heated  at  50°C  for  25  min  has  a  C2  concentration 
which is 30 to 60% of normal,  this partial  C2  deficiency does not explain the 
inability of heated serum to lyse virus-infected cells, since isolated C2, free of 
factor B, failed to reconstitute the lytic activity of such serum, although factor B 
free of C2 was fully active in this regard.  Similarly,  serum immunochemically 
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TABLE  IV 
Site within the IgG Molecule Involved in Initiating C-Dependent Lysis of Cells 
Expressing Viral Antigens on Their Surfaces 
Cells expressing antigens of the following viruses 
Mumps virus*  Measles virus* 
Reagent 
Serum  Serum  Serum  Serum  Fresh se-  50°C, 25  Fresh se-  50°C, 25  50°C, 25  50°C, 25  rum  min +  rum  min +  mm  min  factor B*  factor B 
IgG  95  <10  95  99  <10  99 
F(ab')2  95  <10  95  99  <10  99 
Fab'  <10  <10  <10  <10  <10  <10 
Immune fresh  95  <10  95  99  <10  99 
serum 
* Spontaneous  lysis of cells infected with each virus was 5 +_ 5%. 
$ 250 tLg of factor B per ml of serum. 
TABLE  V 
Effect of Cytochalasin  B and Capping of Viral Antigens on 
Antibody-Mediated Dependent Lysis of HeLa Cells Acutely 
Infected with Measles  Virus 
Cells cap-  Cytochalasin B  ping 
Immune specific lysis 
Heated 56°C/  Fresh serum  30min 
tLg/ml  %  % 
30  3  >95  12 
20  3  >95  10 
10  18  >95  7 
5  42  >95  7 
0  65  >95  5 
depleted of factor B functioned normally at the classical pathway level as shown 
by its normal CH~, value, although such serum was completely unable to lyse 
measles virus-infected cells. 
Further studies were performed to define which alternative pathway compo- 
nents bound to cells in this system. Fluorescence techniques showed the pres- 
ence  of IgG,  properdin,  factor  B,  C3,  and  C4  on  the  surfaces  of HeLa  cells 
infected  with  measles  virus  after  incubation with  human  serum  containing 
antibody to the virus. Factor B binding, although weak, was consistent. None of 
the components were observed bound to virus-infected cells not incubated with 
serum or mixed with serum heated to 56°C or originating from a  child without 
measles virus antibodies. IgG, properdin, factor B,  and C3 were also bound on 
use of C4-depleted serum, findings entirely consistent with alternative pathway 
mediation.  The  finding of C3b  and properdin on the  surfaces of infected cells 
incubated with factor B-depleted serum containing antibody to measles virus 
may reflect binding of C3b with some classical pathway activation or a  direct 1038  ANTIBODY  AND  ALTERNATIVE  C  PATHWAY-MEDIATED  LYSIS 
attack on C3 by cellular enzymes. Properdin binding is explicable in this context 
as it binds to C3b  (20). 
Serum in which C4 was blocked by monospecific Fab' antibody to C4 was fully 
functional in lysing virus-infected cells, whereas serum depleted of factor B by 
Fab antibody to factor B was totally unable to lyse virus-infected cells. In our 
experience the use of Fab' antibody to C4 and Fab antibody to factor B is an 
effective and specific means of segregating the effects of the classical from the 
alternative  C  pathway.  Other  advantages  of the  Fab'  antibody  to  C4  and 
antibody to factor B assay system are that the test is simple, rapid, and avoids 
inadvertent depletion of  other serum components. Furthermore, this test system 
excludes  reactions  from  C-fixing heteroantibodies,  whose  diverse  influences 
may explain  the  discrepancies  in  reports  describing both  the  presence  and 
absence of a prozonal effect with antibody-initiated C lysis (21, 22). 
We observed that F(ab').,, but not Fab' fragments, of IgG-initiated C-depend- 
ent lysis of mumps virus and measles virus-infected cells. Hence, activation of 
C  took place  in the absence of the Fc portion of the molecule. These studies 
represent the first demonstration of F(ab')., activation of alternative C pathway 
in man and indicate that killing of mumps and measles virus-infected cells could 
occur without fixation of C1  and other members of the classicial C pathway, 
since the Fc portion of the molecule is required for these activities. Additional 
evidence for activation of alternative C  pathway by F(ab')._, was provided by 
experiments in which virus-infected cells coated with immune F(ab')~ were not 
lysed by serum devoid of antiviral antibodies and heated at 50°C for 25  min. 
Complete restoration of immune lysis occurred after addition of the C source 
with physiological amounts of factor B. 
The alternative C pathway has also been reported to be activated in guinea 
pig serum by aggregated T  -3 or F(ab')~ complexed with specific antigen in the 
absence of the Fc portion of the molecule (23). Similarly, cell bound rabbit IgG 
can also,  at high concentrations, activate the alternative pathway (24). Yet, 
aggregated human IgG myelomas did not lead to activation of the alternative C 
pathway in normal (25) and C2-deficient human serum  a. The discrepancy of the 
latter findings with ours and with early studies cited above may be explained by 
hypothesizing that IgG and F(ab')., binding to viral antigens on the surfaces of 
infected cells creates a unique spatial configuration which then can trigger the 
alternative C pathway or the release of a  C1 inhibitor by infected cells. 
Even though our results show that antibody initiated lysis of virus-infected 
cells proceeded via the alternative C  pathway and occurred with a  C  source 
deficient in C4, C4 was detected on the surfaces of virus-infected cells incubated 
with immune human serum. This indicates that there is some triggering of the 
classical  pathway which,  however,  is  insufficient to  mediate lysis  of virus- 
infected cells. Ohanian and Borsos found large numbers of C4 molecules bound 
to surfaces of tumor cells incubated with antibody and C in the absence of lysis 
(26). Their experimental conditions were not appropriate for analysis of alterna- 
tive C pathway function. 
In our studies C4 was not required for lysis of cells expressing herpes simplex 
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virus or other viruses on their surfaces. In contrast,  Daniels et al.  (27) showed 
that  addition  of C1  and  C4 in excess to herpes  simplex virus sensitized  with 
antibody  led  to  enhanced  neutralization  of the  virus.  Similarly,  we  earlier 
observed activation of the classical C pathway by purified measles virus in the 
presence of specific antiviral antibody (9). However, measles virus-infected cells 
were lysed exclusively by the alternative  C pathway after incubation with the 
same  antibody  source.  These  observations,  coupled  with  our  finding  with 
F(ab')~,  strongly  suggest that  the  viral  antigen  configuration  on  the  plasma 
membrane  is responsible for the  changes  in  the  bound IgG  molecules which 
permit alternative  C pathway activation.  It is perhaps  relevant that  the only 
other reported example of Ig-initiated activation of the alternative  C pathway 
involves human C and human IgG reacting with cell membrane antigens (28). 
For IgG  antibody-initiated  C-dependent  lysis of cells  infected  with  several 
kinds  of viruses,  a  large  number  of antibody  molecules  must  bind  to  each 
infected  cell  (9,  10). Theoretically  redistribution  and  concentration  of viral 
antigens (capping) covered with antiviral antibody might facilitate activation of 
the alternative C pathway. To evaluate this possibility we studied the ability of 
antibody and  C to lyse virus-infected cells exhibiting different degrees of cap- 
ping.  Utilizing  cytochalasin  and  sodium  azide  as  inhibitors  of capping,  we 
distinctly  segregated  lysis from capping,  indicating  that  immune  lysis could 
occur without capping. 
Finally,  in view of our findings  that  large  numbers  of IgG molecules must 
bind to initiate alternative C pathway activation and immune lysis with three 
different budding RNA viruses and one DNA virus,  probably this pathway is 
common for other viruses budding from membranes.  Although  the biological 
reasons  for  the  requirement  of the  alternative  C  pathway  are  still  obscure, 
nevertheless, our data indicate the value of following the activity of the alterna- 
tive  C  pathway  during  acute  viral  infections  and  considering  the  possible 
impairment or deficiency in this pathway in tissue sites and in patients having 
recurrent or persistent virus infections. 
Summary 
Antibody-mediated C-dependent  lysis of cell lines infected with herpes sim- 
plex type 1 virus, influenza A ° virus, measles virus, and mumps virus occurred 
by the  alternative  C  pathway with the participation  of IgG antibodies.  Lysis 
occurred  only  with  immune  human  sera,  Mg+ +  EGTA  immune  sera,  and 
immune sera depleted of C4 or treated with Fab anti-C4. Lysis did not occur with 
nonimmune sera, Mg+ + EDTA immune sera, and immune sera heated 50°C for 
25 min, depleted of factor B or treated with Fab antifactor B. Lysis was restored 
to heated and factor B immunodepleted immune sera by addition of factor B, but 
not by addition of an excess of C2.  Further  studies showed that  lysis of HeLa 
cells infected with measles virus was induced by both immune IgG and F(ab')2 
but not Fab' in the presence of a nonantibody-containing human C source. Lysis 
of measles  virus-infected  cells  was  also  independent  of movement  of viral 
antigens  on  the  surface  of the  infected  cells,  as  inhibition  of viral  antigen 
capping by cytochalasin B or sodium azide was not associated with abrogation of 
immune lysis. 1040  ANTIBODY  AND  ALTERNATIVE  C  PATHWAY-MEDIATED  LYSIS 
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